Journal of Endocrinology and Metabolism

Editor-in-Chief
Hidekatsu Yanai, MD, PhD, Professor
Vice President, National Center for Global Health and Medicine Kohnodai Hospital, Japan
Head, Department of Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, Japan
Professor, Wayo Women’s University, Japan Read more...

ISSN-print: 1923-2861  |  ISSN-online: 1923-287X  |  Bimonthly  | Open Access  | Aims and Scope

Indexed and covered by: Scopus, Chemical Abstract (CA); EBSCO;
Worldcat; Google Scholar; Google; JournalTOCs; PubMed: selected citations only (NIH supported articles); Clarivate Analytics Emerging Sources Citation Index (ESCI-Web of Science)
Journal archiving and digital preservation:
Portico


Combat the COVID-19

Let's Combat COVID-19 Pandemic Together
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.


Highlights

  • Epicardial Adipose Tissue Thickness as a Reliable Marker of Increased Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

    Epicardial adipose tissue (EAT) is a distinct visceral adipose tissue that is present in between the visceral pericardium and myocardium, in which the coronary arteries are lodged. This tissue releases several inflammatory and atherogenic mediators which lead to the initiation and/or progression of coronary atherosclerosis ...

    Read More >>
  • Association of Diabetes and Severe COVID-19 Outcomes: A Rapid Review and Meta-Analysis

    Addressing the urgent need for evidence on diabetes as a serious comorbidity for severe illness and death from coronavirus disease 2019 (COVID-19), we investigated the association between diabetes and COVID-19 disease severity in patients hospitalized due to COVID-19.

    Read More >>
  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis

    The presence of nonalcoholic fatty liver diseases (NAFLDs) and type 2 diabetes was associated with elevated risks of cardiovascular events as well as the progression of NAFLD to fibrosis/cirrhosis and hepatocellular carcinoma.

    Read More >>
  • Effects of Policosanol in Patients With Metabolic Syndrome: A Six-Month Study

    The metabolic syndrome comprises a set of cardiovascular risk factors represented by obesity of central distribution, dyslipidemias, glucose metabolism abnormalities and arterial hypertension, closely associated with insulin resistance. The aim of this study is to investigate in the medium term the effects of policosanol in patients with metabolic syndrome, as well as its safety and tolerability.

    Read More >>
  • Acute Pancreatitis in a Patient With Parathyroid Carcinoma

    Parathyroid carcinoma is a rare endocrine malignancy. Clinical features of parathyroid carcinoma are mainly due to the effects of primary hyperparathyroidism (PHPT). Hypercalcemia produced by primary or secondary hyperparathyroidism is a rare and unclear cause of acute pancreatitis.

    Read More >>

Viewpoints

 

 

Featured

 

What Are the Changes and Burden Associated With COVID-19 in Diabetes Management and Delivery of the Diabetes Services?

Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that has spread to almost all countries worldwide. Diabetes mellitus (DM) has been shown to increase the risk of COVID-19 disease severity. In this review, we provide a summary of the impact of COIVD-19 on diabetes management and related services. Full Text

Combination Therapy of Alpha-Glucosidase Inhibitor, Thiazolidinedione and Sodium Glucose Co-Transporter-2 Inhibitor in Japanese Type 2 Diabetes Patients

We additionally administered selective inhibitor of sodium glucose co-transporter-2 (SGLT2) inhibitor to type 2 diabetic patients on ?-glucosidase inhibitor (?-GI) and/or thiazolidinedione (TZD), to determine whether the multi-drug combination therapy including SGLT2 inhibitor further improved the glycemic control in Japanese patients with diabetes mellitus. Full Text


Image of the Issue

 

Giant Prolactinomas: Case Series and Review of the Literature
Giant prolactinomas can pose unique diagnostic and management challenges because of atypical presentations and confounding laboratory assessments. We present four cases of giant prolactinomas each presenting in a unique manner and discuss the diagnostic and management dilemmas associated with them. Full Text


Current Issue

 


Vol. 10, No. 6, Dec 2020

Table of Contents

Review

What Are the Changes and Burden Associated With COVID-19 in Diabetes Management and Delivery of the Diabetes Services? Abstract HTML PDF
Rohan Sadera, Joyce Youssef, Azza Ramadan, Mohamed H. Ahmed 155-161
doi: https://doi.org/10.14740/jem699
Statins for Patients With Non-Alcoholic Fatty Liver Disease Abstract HTML PDF
Talal Shakas AlGhamdi 162-166
doi: https://doi.org/10.14740/jem705

Original Article

Combination Therapy of Alpha-Glucosidase Inhibitor, Thiazolidinedione and Sodium Glucose Co-Transporter-2 Inhibitor in Japanese Type 2 Diabetes Patients Abstract HTML PDF
Masataka Kusunoki, Naomi Wakazono, Naomi Wakazono, Kazuhiko Tsutsumi, Kazuhiko Tsutsumi, Yoshiharu Oshida, Yoshiharu Oshida, Tesuro Miyata, Tesuro Miyata 167-172
doi: https://doi.org/10.14740/jem708
Epicardial Adipose Tissue Thickness as a Reliable Marker of Increased Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus Abstract HTML PDF
Bhavana Mastebhakti, Sandeep Garg, Naresh Gupta, Sapna Singh, Sunita Aggarwal, Ranvijay Singh 173-181
doi: https://doi.org/10.14740/jem710

Case Report

Giant Prolactinomas: Case Series and Review of the Literature Abstract HTML PDF
Vishnu Vardhan Garla, Shiva Gosi, Sravanthi Palakodety, Swetha Kanduri, Karthik Kovvuru, Manasa Gunturu, Lillian Lien 182-189
doi: https://doi.org/10.14740/jem652
A Case of Etomidate Use in Management of Adrenocortical Carcinoma With Hypercortisolemia Abstract HTML PDF
Sharifah Faradila Wan Muhamad Hatta, Rachel Daly, Cyril Chacko, Rajeev Raghavan 190-194
doi: https://doi.org/10.14740/jem682
 

Browse  Journals  

 

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.             
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.